دورية أكاديمية

Total Synthesis and Antimalarial Activity of 2-( p -Hydroxybenzyl)-prodigiosins, Isoheptylprodigiosin, and Geometric Isomers of Tambjamine MYP1 Isolated from Marine Bacteria.

التفاصيل البيبلوغرافية
العنوان: Total Synthesis and Antimalarial Activity of 2-( p -Hydroxybenzyl)-prodigiosins, Isoheptylprodigiosin, and Geometric Isomers of Tambjamine MYP1 Isolated from Marine Bacteria.
المؤلفون: Kancharla P; Department of Chemistry, Portland State University, Portland, Oregon 97201, United States., Li Y; Department of Veterans Affairs Medical Center, Portland, Oregon 97239, United States., Yeluguri M; Department of Chemistry, Portland State University, Portland, Oregon 97201, United States., Dodean RA; Department of Veterans Affairs Medical Center, Portland, Oregon 97239, United States., Reynolds KA; Department of Chemistry, Portland State University, Portland, Oregon 97201, United States., Kelly JX; Department of Chemistry, Portland State University, Portland, Oregon 97201, United States.; Department of Veterans Affairs Medical Center, Portland, Oregon 97239, United States.
المصدر: Journal of medicinal chemistry [J Med Chem] 2021 Jun 24; Vol. 64 (12), pp. 8739-8754. Date of Electronic Publication: 2021 Jun 10.
نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE
أسماء مطبوعة: Publication: Washington Dc : American Chemical Society
Original Publication: [Easton, Pa.] : American Chemical Society, [c1963-
مواضيع طبية MeSH: Antimalarials/*therapeutic use , Prodigiosin/*analogs & derivatives , Prodigiosin/*therapeutic use , Pyrroles/*therapeutic use, Animals ; Antimalarials/chemical synthesis ; Antimalarials/toxicity ; Female ; Hep G2 Cells ; Humans ; Mice ; Molecular Structure ; Parasitic Sensitivity Tests ; Plasmodium falciparum/drug effects ; Plasmodium yoelii/drug effects ; Prodigiosin/toxicity ; Pyrroles/chemical synthesis ; Pyrroles/toxicity ; Stereoisomerism ; Structure-Activity Relationship
مستخلص: Highly efficient and straightforward synthetic routes toward the first total synthesis of 2-( p -hydroxybenzyl)-prodigiosins ( 2 - 5 ), isoheptylprodigiosin ( 6 ), and geometric isomers of tambjamine MYP1 (( E / Z )- 7 ) have been developed. The crucial steps involved in these synthetic routes are the construction of methoxy-bipyrrole-carboxaldehydes (MBCs) and a 20-membered macrocyclic core and a regioselective demethylation of MBC analogues. These new synthetic routes enabled us to generate several natural prodiginines 24 - 27 in larger quantity. All of the synthesized natural products exhibited potent asexual blood-stage antiplasmodial activity at low nanomolar concentrations against a panel of Plasmodium falciparum parasites, with a great therapeutic index. Notably, prodiginines 6 and 24 - 27 provided curative in vivo efficacy against erythrocytic Plasmodium yoelii at 25 mg/kg × 4 days via oral route in a murine model. No overt clinical toxicity or behavioral change was observed in any mice treated with prodiginines and tambjamines.
References: Chemistry. 2011 Dec 9;17(50):14074-83. (PMID: 22069220)
Org Lett. 2007 Nov 22;9(24):5127-30. (PMID: 17963401)
Blood. 2007 Jun 15;109(12):5430-8. (PMID: 17332241)
J Nat Prod. 2008 Nov;71(11):1970-2. (PMID: 18922034)
Org Biomol Chem. 2013 Jun 21;11(23):3834-45. (PMID: 23640568)
Chem Biol Interact. 2008 Aug 11;174(3):155-62. (PMID: 18573243)
J Org Chem. 2000 Jan 14;65(1):164-8. (PMID: 10813911)
Malar J. 2011 May 24;10:144. (PMID: 21609473)
J Nat Prod. 2020 Mar 27;83(3):770-803. (PMID: 32162523)
J Med Chem. 2020 Jun 11;63(11):6179-6202. (PMID: 32390431)
Bioorg Med Chem Lett. 2010 Sep 1;20(17):5207-11. (PMID: 20655217)
J Med Chem. 2007 Apr 5;50(7):1528-36. (PMID: 17348639)
Curr Med Chem Anticancer Agents. 2001 Aug;1(2):195-218. (PMID: 12678767)
Angew Chem Int Ed Engl. 2003 Aug 11;42(31):3582-603. (PMID: 12916029)
Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19512-7. (PMID: 18040043)
J Nat Prod. 2004 Dec;67(12):2141-53. (PMID: 15620274)
Molecules. 2005 Oct 31;10(10):1286-91. (PMID: 18007521)
J Org Chem. 1999 Apr 30;64(9):3379-3380. (PMID: 11674451)
J Org Chem. 2014 Dec 5;79(23):11674-89. (PMID: 25380131)
Medchemcomm. 2019 Mar 1;10(3):478-483. (PMID: 31015911)
Nat Prod Rep. 2005 Apr;22(2):162-95. (PMID: 15806196)
Trans R Soc Trop Med Hyg. 2006 Jun;100(6):505-8. (PMID: 16566952)
Org Lett. 2017 Mar 17;19(6):1298-1301. (PMID: 28271893)
J Med Chem. 2011 Aug 11;54(15):5296-306. (PMID: 21736388)
Nature. 1967 Mar 4;213(5079):903-4. (PMID: 6030049)
Environ Microbiol. 2007 Mar;9(3):814-8. (PMID: 17298379)
Clin Lymphoma Myeloma Leuk. 2010 Aug;10(4):285-9. (PMID: 20709666)
Chem Rev. 2016 Jul 27;116(14):7818-53. (PMID: 27314508)
Antimicrob Agents Chemother. 2004 May;48(5):1803-6. (PMID: 15105138)
Exp Parasitol. 1969 Aug;25(1):32-49. (PMID: 4983051)
J Antibiot (Tokyo). 1993 Dec;46(12):1799-803. (PMID: 8294236)
J Med Chem. 2015 Sep 24;58(18):7286-309. (PMID: 26305125)
J Org Chem. 1999 Sep 3;64(18):6861-6869. (PMID: 11674696)
Biochim Biophys Acta. 1967 Feb 7;136(1):182-4. (PMID: 5340231)
J Med Chem. 2000 Jun 29;43(13):2557-65. (PMID: 10891115)
RSC Adv. 2020;10(40):24017-24026. (PMID: 33456769)
J Immunol Methods. 1990 Aug 7;131(2):165-72. (PMID: 2391427)
J Nat Prod. 2020 May 22;83(5):1495-1504. (PMID: 32275146)
معلومات مُعتمدة: R01 AI141972 United States AI NIAID NIH HHS
المشرفين على المادة: 0 (Antimalarials)
0 (Pyrroles)
0 (tambjamine MYP1)
OL369FU7CJ (Prodigiosin)
تواريخ الأحداث: Date Created: 20210610 Date Completed: 20210825 Latest Revision: 20211214
رمز التحديث: 20240829
مُعرف محوري في PubMed: PMC8244818
DOI: 10.1021/acs.jmedchem.1c00748
PMID: 34111350
قاعدة البيانات: MEDLINE
الوصف
تدمد:1520-4804
DOI:10.1021/acs.jmedchem.1c00748